Controlled study of treatment for disseminated intravascular coagulation in the neonate.
Thirty-three neonates with disseminated intravascular coagulation were assigned randomly to one of three treatment groups: (1) exchange transfusion, (2) administration of fresh-frozen plasma and platelets, and (3) control (no therapy directed specifically at the coagulopathy). The three groups were comparable for degree of abnormality in initial coagulation studies and underlying pathologic processes. Shock was a common accompaniment of DIC and occurred in 85% of all infants. In all cases, underlying disease states and shock were treated aggressively. Resolution of DIC and survival were not different in the three treatment groups. Outcome of DIC was dependent on the success of treatment of the underlying pathologic process and aggressive supportive care, including restoration of blood pressure, but was not altered by therapy specifically directed at the coagulopathy.
D001803:Blood Transfusion; D002986:Clinical Trials as Topic; D004211:Disseminated Intravascular Coagulation / Q000209:etiology / Q000628:therapy*; D005078:Exchange Transfusion, Whole Blood; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000628:therapy*; D010949:Plasma; D017713:Platelet Transfusion; D011897:Random Allocation; D012769:Shock / Q000150:complications / Q000628:therapy